A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study)

ClinicalTrials.gov Identifier: NCT02840669, First received: July 19, 2016

Locations: Hôpital Pitié-Salpêtrière, Paris, France, Sponsors and Collaborators: Annapurna Therapeutics, Adverum Biotechnologies & Weill Medical College of Cornell University

This study is designed to characterize the cardiac manifestations of FA using cardiac magnetic resonance (CMR), echocardiography, serum cardiac biomarkers and evaluation of fatigue severity, in the context of the neurological disease.

Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Diagnostic

 A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study)